RDHL · RedHill Biopharma Ltd. · Documents
Market Cap
$3.76M
Shares
8.89M
Volume · Oct 23
108.14K
Avg daily vol (3M)
2.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2021-09-07 | — | |
| 6-K | — | 2021-09-02 | — | |
| 6-K | — | 2021-08-26 | — | |
| 6-K | — | 2021-08-26 | 2021-06-30 | |
| 6-K | — | 2021-08-23 | — | |
| 6-K | — | 2021-08-19 | — | |
| F-3 | — | 2021-07-29 | — | |
| 6-K | — | 2021-07-26 | — | |
| 6-K | — | 2021-07-22 | — | |
| 6-K | — | 2021-07-20 | — | |
| 6-K | — | 2021-07-19 | — | |
| 6-K | — | 2021-07-13 | — | |
| 6-K | — | 2021-06-28 | — | |
| 6-K | — | 2021-06-21 | — | |
| 6-K | — | 2021-06-17 | — | |
| 6-K | — | 2021-06-10 | — | |
| 6-K | — | 2021-06-09 | — | |
| 6-K | — | 2021-06-07 | — | |
| 6-K | — | 2021-05-27 | — | |
| 6-K | — | 2021-05-26 | — | |
| SC TO-I/A | — | 2021-05-26 | — | |
| 6-K | — | 2021-05-26 | — | |
| 6-K | — | 2021-05-24 | — | |
| 6-K | — | 2021-05-21 | — | |
| 6-K | — | 2021-05-20 | — | |
| SC TO-I | — | 2021-04-26 | — | |
| 6-K | — | 2021-04-09 | — | |
| F-3 | — | 2021-03-30 | — | |
| 6-K | — | 2021-03-25 | — | |
| 6-K | — | 2021-03-22 | — | |
| 20-F | — | 2021-03-18 | 2020-12-31 | |
| 6-K | — | 2021-03-18 | — | |
| 6-K | — | 2021-03-11 | — | |
| 6-K | — | 2021-03-05 | — | |
| 6-K | — | 2021-03-04 | — | |
| 6-K | — | 2021-02-23 | — | |
| 6-K | — | 2021-02-18 | — | |
| 6-K | — | 2021-02-17 | — | |
| 6-K | — | 2021-02-09 | — | |
| 6-K | — | 2021-02-02 | — | |
| 6-K | — | 2021-01-29 | — | |
| 6-K | — | 2021-01-28 | — | |
| 6-K | — | 2021-01-14 | — | |
| 6-K | — | 2021-01-14 | — | |
| 6-K | — | 2021-01-11 | — | |
| 6-K | — | 2021-01-11 | — | |
| 6-K | — | 2021-01-06 | — | |
| 6-K | — | 2020-12-31 | — | |
| 6-K | — | 2020-12-22 | — | |
| 6-K | — | 2020-12-15 | — |
Showing 251–300 of 382 filings